Search results
Showing: 10 of 2097
NICE Technology Appraisals in the NHS in England (Innovation Scorecard) - to December 2023
Overview
Published 25 April 2024.
Summary
The Innovation Scorecard reports on the use of medicines and medicine groupings in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE…
Drug Tariff news - April Part VIIIA reimbursement prices
The Department of Health has agreed that the April Drug Tariff Part VIIIA reimbursement price for
Baclofen 10mg tablets £7.20
Digoxin 125microgram tablets £4.89
Digoxin 250microgram tablets £4.62
Digoxin 62.5microgram tablets £4.75
Fosinopril…
Drug Tariff news - April Part VIIIA reimbursement prices
The Department of Health has agreed that the April Drug Tariff Part VIIIA reimbursement price for the following items will be:
Clonidine 25microgram tablets £7.50
Exemestane 25mg tablets £33.00
Trimethoprim 200mg tablets 6pack £2.79…
Drug Tariff news - April Part VIIIA reimbursement prices
The Department of Health has agreed that the April Drug Tariff Part VIIIA reimbursement prices for the following items will be:
Mebeverine 135mg tablets £18.50
Olsalazine 250mg capsules £75.00
Olsalazine 500mg tablets £85.00
and not as…
Guidance and glossary
Background
Innovation scorecard overview
The Innovation Scorecard is an action taken from the Department of Health and Social Care's (DHSC) paper titled "Innovation Health and Wealth: Accelerating Adoption and Diffusion in the NHS" (IHW)…
Background and introduction
Background
In December 2011, the Department of Health and Social Care (DHSC) set out plans to support the development, adoption and spread of innovation in the NHS. It published a report titled "Innovation, Health and Wealth, accelerating adoption…
Estimates Report
Key findings
The comparison of expected uptake to the actual volume of medicines used in the NHS in England is available in the national level medicine groupings interactive dashboard.
You can find the dashboard on the online web platform.
The…
Assumed Daily Dose (ADD) methodology
Introduction
This section explains the use of Assumed Daily Doses (ADDs) for measuring medicine utilisation in the Innovation Scorecard. It discusses why ADDs are used, how they are used in calculations, and the principles applied to assign ADDs.…
Drug Tariff news - May Part VIIIB
May Part VIIIB has been updated to include basic prices which will apply to prescriptions from 1st May 2015
Part VIIIB May 2015
Background Quality Notes
Introduction
This section of the report aims to provide users with an evidence-based assessment of the quality of the publication outputs. The quality of the outputs is assessed based on the nine European Statistical System (ESS) quality dimensions…